Insider Sale: Group President, Delivery Marc Krug Sells 13,657 Shares of Cross Country ...
Cross Country Healthcare(CCRN.US) Officer Sells US$202.4K in Common Stock
$Cross Country Healthcare(CCRN.US)$ Officer Krug Marc S. sold 13,657 shares of common stock on May 30, 2024 at an average price of $14.82 for a total value of $202.4K.Source: Announcement What is stat
Investors in Cross Country Healthcare (NASDAQ:CCRN) Have Seen Notable Returns of 96% Over the Past Five Years
Insider Sale: Chief Information Officer Phillip Noe Sells Shares of Cross Country Healthcare ...
Cross Country Healthcare(CCRN.US) Officer Sells US$136.88K in Common Stock
$Cross Country Healthcare(CCRN.US)$ Officer Noe Phillip Lyn sold 9,646 shares of common stock on May 23, 2024 at an average price of $14.19 for a total value of $136.88K.Source: Announcement What is s
Cross Country Healthcare to Attend Citizens JMP Medical Devices and Healthcare Services Forum
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in the Citizens JMP Medical Devices and Healthcare Services Forum taking place June 20, 2024 at the Boston
Cross Country Healthcare Approves New Incentive Plan
Cross Country Healthcare to Attend the William Blair 44th Annual Growth Stock Conference and the Jefferies Global Healthcare Conference
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in two upcoming conferences: The William Blair 44th Annual Growth Stock Conference taking place June
There May Be Reason For Hope In Cross Country Healthcare's (NASDAQ:CCRN) Disappointing Earnings
Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) earnings announcement last week didn't impress shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced b
Cross Country Healthcare (CCRN) Gets a Hold From Truist Financial
Cross Country Healthcare, Inc.: Expect to Take Bad Debt Charge in 2Q24, Associated With Customer Bankruptcy >CCRN
Cross Country Healthcare, Inc.: Expect to Take Bad Debt Charge in 2Q24, Associated With Customer Bankruptcy >CCRN
Declining Stock and Decent Financials: Is The Market Wrong About Cross Country Healthcare, Inc. (NASDAQ:CCRN)?
With its stock down 21% over the past three months, it is easy to disregard Cross Country Healthcare (NASDAQ:CCRN). But if you pay close attention, you might find that its key financial indicators l
Cross Country Healthcare Is Maintained at Outperform by Barrington Research
Cross Country Healthcare Is Maintained at Outperform by Barrington Research
Barrington Research: Maintaining the Cross Country Healthcare (CCRN.US) rating, adjusted from better than market to better than market rating, and adjusted target price from $24.00 to $21.00.
Barrington Research: Maintaining the Cross Country Healthcare (CCRN.US) rating, adjusted from better than market to better than market rating, and adjusted target price from $24.00 to $21.00.
Barrington Research Maintains Outperform on Cross Country Healthcare, Lowers Price Target to $21
Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and lowers the price target from $24 to $21.
Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating
Cross Country Healthcare (CCRN) has an average rating of hold and price targets ranging from $16 to $24, according to analysts polled by Capital IQ.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cross Country Healthcare (CCRN), Castle Biosciences (CSTL) and Andlauer Healthcare Group (OtherANDHF)
Cross Country Healthcare Issues Informative Press Statement
Cross Country Healthcare to Attend Benchmark's Healthcare House Call Investor Conference
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in Benchmark's Healthcare House Call Virtual One-on-One Investor Conference taking place May 21-22, 2024.
Cross Country Healthcare First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
No Data